1. Short title This Act may be cited as the Abuse Deterrent and Prescriber Training Act of 2018 or the ADAPT Act of 2018 . 2. Practitioner education (a) In general Part C of the Controlled Substances Act ( 21 U.S.C. 821 et seq.) is amended— (1) in section 303 ( 21 U.S.C. 823 ), by adding at the end the following: (k) (1) The Attorney General shall not register, or renew the registration of, a practitioner under subsection (f) who is licensed under State law to prescribe controlled substances in schedule II, III, IV, or V, unless the practitioner submits to the Attorney General, for each such registration or renewal request, a written certification that the practitioner has completed 3 hours of training under a training program meeting the criteria in paragraph (2) during the period applicable under paragraph (5). (2) A training program meets the criteria in this paragraph if the program— (A) includes information on— (i) safe opioid prescribing guidelines, including the Guideline for Prescribing Opioids for Chronic Pain issued by the Centers for Disease Control and Prevention; (ii) the risks of opioid medications and other prescription drugs that are controlled substances; (iii) pain management, including the need to provide individualized care particularly for active cancer treatment, palliative care, and end-of-life care; (iv) early detection of opioid and other substance use disorders; (v) the risks of prescribing opioids to any individual in recovery from a substance use disorder; (vi) a basic understanding of addiction; (vii) the treatment of opioid-dependent patients and their treatment options; (viii) the risks of misuse of all prescription drugs that are controlled substances; and (ix) alternative non-opioid pain management medications and other effective treatments; and (B) is— (i) approved by the State agency with primary responsibility for licensing the practitioner to prescribe controlled substances